New study demonstrates that stem cells can be used to treat complications of diabetes

New study demonstrates that stem cells can be used to treat complications of diabetes

A new study from the University of Illinois (UI) has concluded that meneschymal stem cells (MSC) can stimulate the growth of new blood vessels, according to an article in Global Times.

The study found that injecting MSC from muscle cells into mice promoted the growth of new blood vessels, which in turn had a positive effect on blood circulation in the surrounding tissues. It is thought that Peripheral Artery Disease (PAD), a condition associated with diabetes which can cause pain to the sufferer and can even lead to surgery or limb amputation, could be successfully treated with this method.

Marni Boppart, UI professor of kinesiology and community health, said “We clearly demonstrated the capacity for MSCs to increase angiogenesis, peripheral perfusion and muscle function, and we saw that MSCs promoted muscle healing by creating new vessels in the tissue that compensated for restricted blood flow. MSC transplantation provides the opportunity to maximize vessel growth in PAD to maintain or rejuvenate skeletal muscle.”

Grace Century partner project Provia produces “Store-A-Tooth” which is a cutting edge biobanking solution specially tailored towards the storage of dental stem cells.

Grace Century President and Director of Research Scott Wolf commented “This study is further evidence that MSCs – which are the same as those found in dental stem cells – can affect diseases positively like Diabetes. Positive studies and news on this subject continue to come in from all parts of the globe.”

Read the full story on Global Times here.